William D. Claypool
Chief Executive Officer at Hsiri Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dennis F. Willson | M | - |
Hsiri Therapeutics, Inc.
 Hsiri Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Hsiri Therapeutics LLC engages in the discovering and developing therapies for infections due to drug resistant bacteria. Its research efforts are focuses on two major areas including infections due to mycobacteria and infections due to usual bacterial pathogens. The firm also developing compounds aimed at traditional bacterial infections caused by drug resistant bacteria. The company was founded by Dennis F. Willson and is headquartered in Media, PA.
NP-C Therapeutics LLC
 NP-C Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services NP-C Therapeutics LLC develops pharmaceutical products for treatment of Niemann-Pick Type C disease. The company was incorporated in 2014 and is headquartered in King of Prussia, PA. | - |
| Harold Wolkin | M | 72 | 8 years | |
| Denny Willson | M | - |
Ranedis Pharmaceuticals
 Ranedis Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ranedis Pharmaceuticals operates as a biopharmaceutical company. The company was founded by William Claypool and Denny Willson and is headquartered in Media, PA. | - |
| Carrie Frey | F | - |
Ranedis Pharmaceuticals
Ranedis Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ranedis Pharmaceuticals operates as a biopharmaceutical company. The company was founded by William Claypool and Denny Willson and is headquartered in Media, PA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Larry Andrews | M | 71 | 10 years | |
| David C. U'Prichard | M | 75 |
Smithkline Beecham Pharmaceuticals (India) Ltd.
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 6 years |
| Gerald P. McDole | M | 84 | 12 years | |
| Francis Raymond Salemme | M | 78 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 10 years |
| Martyn Greenacre | M | 82 |
Smithkline Beecham Pharmaceuticals (India) Ltd.
| 3 years |
| Thomas Wellner | M | 59 | 3 years | |
| Mark A. Beaudet | M | - | 3 years | |
| Christian Godin | M | - | 7 years | |
| William Charles Garriock | M | 85 | 9 years | |
| Shawn O'Brien | M | - | 3 years | |
| Joan Chypyha | F | 57 | 4 years | |
| Lynne Bulger | F | - | 2 years | |
| Louise Blythe | F | - | 1 years | |
| Linda Angaritis | F | - | 4 years | |
| Ralph Bohrer | M | - | 1 years | |
| Brian Rosenberger | M | 55 | 2 years | |
| Mark Spina | M | - | - | |
| Charles F. Jenkins | M | - | - | |
| Joseph Pecora | M | - | - | |
| Rosemary Crane | F | 64 | - | |
| Edward F. Smith | M | 70 |
Smithkline Beecham Pharmaceuticals (India) Ltd.
| 6 years |
| John Vavricka | M | 60 |
Smithkline Beecham Pharmaceuticals (India) Ltd.
| 12 years |
| Renee Tannenbaum | M | 72 | - | |
| John Donald MacInnis | M | - | 3 years | |
| Tim Bertram | M | 68 |
Smithkline Beecham Pharmaceuticals (India) Ltd.
| 3 years |
| Tuan Elstrom | M | - | 2 years | |
| Stephen Boccardo | M | - |
Phoenix Data Systems, Inc.
 Phoenix Data Systems, Inc. Information Technology ServicesTechnology Services Phoenix Data Systems, Inc. provides electronic data capture and data management services for the pharmaceutical industries. Its services include reporting, training, and coding. The company was founded in 1997 and is headquartered in King of Prussia, PA. | - |
| Richard M. Soll | M | - |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 8 years |
| Michael Brooks | M | 46 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 22 | 66.67% |
| United States | 7 | 21.21% |
| India | 5 | 15.15% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William D. Claypool
- Personal Network
